| Previous close | 382.93 |
| Open | N/A |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 370.00 |
| Expiry date | 2024-10-18 |
| Day's range | 382.93 - 382.93 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksPharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
Investor's Business DailyHow A Top Fund Beats The Market By Owning Future Leaders
Julianne McHugh, lead manager of best mutual fund BNY Mellon Large Cap Securities, isn't interested in blue-chip stars of yesteryear.
ZacksZacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
Eaton, Eli Lilly and Arista Networks have been highlighted in this Investment Ideas article.
© 2024 Yahoo. All rights reserved.